Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging phase II study of S44497 in type 2 diabetes mellitus versus placebo, glimepiride and sitagliptin
2007-003808-35Phase 2Completed
- Sponsor
- Servier Research and Development Ltd.
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S44497 in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Servier Research and Development Ltd. Primary endpoint: 24-hour glucose profile. Started Sep 2007; status: completed.
02
Drugs
S44497
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-003808-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003808-35.